OpenAI

Microsoft and OpenAI may be renegotiating their partnership

OpenAI is currently in “a tough negotiation” with its biggest investor and partner, Microsoft, according to the Financial Times. The AI startup recently announced a major change to its corporate restructuring plans — while it still aims to convert its business arm into a for-profit public benefit corporation, its nonprofit board will still be in […]

Microsoft and OpenAI may be renegotiating their partnership Read More »

OpenAI’s enterprise adoption appears to be accelerating, at the expense of rivals

OpenAI appears to be pulling well ahead of rivals in the race to capture enterprises’ AI spend, according to transaction data from fintech firm Ramp. According to Ramp’s AI Index, which estimates the business adoption rate of AI products by drawing on Ramp’s card and bill pay data, 32.4% of U.S. businesses were paying for

OpenAI’s enterprise adoption appears to be accelerating, at the expense of rivals Read More »

ChatGPT’s deep research tool gets a GitHub connector to answer questions about code

OpenAI is enhancing its AI-powered “deep research” feature with the ability to analyze codebases on GitHub. On Thursday, OpenAI announced what it’s calling the first “connector” for ChatGPT deep research, the company’s tool that searches across the web and other sources to compile thorough research reports on a topic. Now, ChatGPT deep research can link

ChatGPT’s deep research tool gets a GitHub connector to answer questions about code Read More »

OpenAI launches a data residency program in Asia

OpenAI is introducing a new data residency program in Asia, the company announced Thursday, following the rollout of its data residency program in Europe in February. The new program, which is available for OpenAI’s ChatGPT Enterprise, ChatGPT Edu, and the OpenAI API, aims to help Asia-based organizations meet local data sovereignty requirements while using the

OpenAI launches a data residency program in Asia Read More »

OpenAI and the FDA are reportedly discussing AI for drug evaluations

OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation

OpenAI and the FDA are reportedly discussing AI for drug evaluations Read More »

OpenAI wants to team up with governments to grow AI infrastructure

OpenAI is launching a program, OpenAI for Countries, that the company says will enable it to build out the local infrastructure needed to better serve international AI customers. As a part of the new program, OpenAI will partner with governments to assist with efforts like building out data center capacity and customizing OpenAI’s products, including

OpenAI wants to team up with governments to grow AI infrastructure Read More »

What OpenAI’s restructuring plan means for its corporate future

OpenAI said on Monday it is pursuing a new restructuring plan after conversations with Delaware and California’s attorneys general, both of whom were closely watching as OpenAI tried to break free of its odd corporate structure. Currently, OpenAI’s nonprofit board governs the organization’s for-profit operations. Under the new plan, OpenAI’s for-profit arm will become a

What OpenAI’s restructuring plan means for its corporate future Read More »